Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.OBI Pharma’s OBI-3424 gets FDA orphan drug status to treat ALL
Image: FDA grants orphan drug designation to OBI Pharma’s OBI-3424 for the treatment of ALL. Photo: courtesy of The U.S. Food and Drug Administration/Wikipedia.org.
Image: FDA grants orphan drug designation to OBI Pharma’s OBI-3424 for the treatment of ALL. Photo: courtesy of The U.S. Food and Drug Administration/Wikipedia.org.